Epratuzumab Tesirine Antibody
Epratuzumab Tesirine (ADCT-602) is a CD22-directed antibody-drug conjugate (ADC) for research use, utilizing the cytotoxic payload SG3249, a pyrrolobenzodiazepine (PBD) dimer. It is applied in preclinical oncology research, including in vitro cytotoxicity assays and in vivo xenograft studies targeting B-cell malignancies.
Product Specifications
Target
Antibody-Drug Conjugates (ADCs)
Conjugation
Unconjugated
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740017-500 1x 500 µL
Ep-CAM / CD326 (VU-1D9), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470745-100 1x 100 µL
CD45 / LCA (2B11 + PD7/26), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041176-100 1x 100 µL
EMI1 (EMI1/1176), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details